← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

M

$ Value

$0

Shares

2,034

Price

$0

Filed

Dec 8

Insider

Name

Aryeh Jason

Title

CIK

0001376960

Roles

Director

Transaction Details

Transaction Date

2025-12-08

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds. | This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2016, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Filing Info

Accession No.

0002001011-25-000122

Form Type

4

Issuer CIK

0000886163

Aryeh Jason's History

Date Ticker Type Value
2025-12-08 LGND M $141K
2025-12-08 LGND M $0
2025-09-23 LGND $753K
2025-09-23 LGND $791K
2025-09-23 LGND $164K
2025-09-19 OBIO $2K
2025-08-07 OBIO A $0
2025-07-15 LFCR A
2025-06-24 OBIO A $0
2025-06-24 OBIO A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01